IGF-1 LR3 is a long-acting insulin-like growth factor variant studied for roles in cell signaling, muscle protein synthesis, and recovery dynamics. In lab models it is explored for potential effects on hypertrophy pathways, wound repair, and metabolic adaptation. The LR3 modification extends stability and bioactivity versus native IGF-1, supporting wider experimental windows.
Handle under sterile conditions. Reconstitute only with suitable diluent per lab protocol. Store refrigerated at 2 to 8 C, protected from light. Avoid repeated freeze thaw cycles. Consult current literature and institutional safety guidelines before use.